Andriy V Trailin (Andriy Trailin)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 10

Top Topics

Small Cell Lung Cancer

Dendritic Cells

Liver Metastases

Top Venues

International journal of molecular sciences

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Phanindra Babu Kasi, Venkata Ramana Mallela, Filip Ambrozkiewicz, Andriy V Trailin, Václav Liška, Kari Hemminki
Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. International journal of molecular sciences 24 (9) (2023)
Phanindra Babu Kasi, Venkata Ramana Mallela, Filip Ambrozkiewicz, Andriy V Trailin, Václav Liška, Kari Hemminki
Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. International journal of molecular sciences 24 (9) (2023)
Esraa Ali, Andriy V Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International journal of molecular sciences 23 (23) (2022)
Esraa Ali, Andriy V Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International journal of molecular sciences 23 (23) (2022)
Marie Rajtmajerová, Andriy V Trailin, Václav Liška, Kari Hemminki, Filip Ambrozkiewicz
Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment. Cancers 14 (21) (2022)
Esraa Ali, Andriy V Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International journal of molecular sciences 23 (23) (2022)
Esraa Ali, Andriy V Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International journal of molecular sciences 23 (23) (2022)
Andriy V Trailin, Lenka Červenková, Filip Ambrozkiewicz, Esraa Ali, Phanindra Kasi, Richard Pálek, Petr Hošek, Vladislav Třeška, Ondřej Daum, Zbynek Tonar, Václav Liška, Kari Hemminki
T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis. Cancers 14 (3) (2022)
Andriy V Trailin, Tetyana I Ostapenko, Tamara N Nykonenko, Svitlana N Nesterenko, Olexandr S Nykonenko
Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival. Disease markers 2017 (2017)
Oleg A Levada, Nataliya V Cherednichenko, Andriy V Trailin, Alexandra S Troyan
Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study. Disease markers 2016 (2016)